6-112136188-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001105206.3(LAMA4):​c.3349G>A​(p.Gly1117Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.737 in 1,611,098 control chromosomes in the GnomAD database, including 440,616 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 45980 hom., cov: 32)
Exomes 𝑓: 0.73 ( 394636 hom. )

Consequence

LAMA4
NM_001105206.3 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 3.50

Publications

39 publications found
Variant links:
Genes affected
LAMA4 (HGNC:6484): (laminin subunit alpha 4) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the alpha chain isoform laminin, alpha 4. The domain structure of alpha 4 is similar to that of alpha 3, both of which resemble truncated versions of alpha 1 and alpha 2, in that approximately 1,200 residues at the N-terminus (domains IV, V and VI) have been lost. Laminin, alpha 4 contains the C-terminal G domain which distinguishes all alpha chains from the beta and gamma chains. The RNA analysis from adult and fetal tissues revealed developmental regulation of expression, however, the exact function of laminin, alpha 4 is not known. Tissue-specific utilization of alternative polyA-signal has been described in literature. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2011]
LAMA4 Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy 1JJ
    Inheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Illumina
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.803636E-7).
BP6
Variant 6-112136188-C-T is Benign according to our data. Variant chr6-112136188-C-T is described in ClinVar as Benign. ClinVar VariationId is 44376.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.852 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA4NM_001105206.3 linkc.3349G>A p.Gly1117Ser missense_variant Exon 25 of 39 ENST00000230538.12 NP_001098676.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA4ENST00000230538.12 linkc.3349G>A p.Gly1117Ser missense_variant Exon 25 of 39 1 NM_001105206.3 ENSP00000230538.7

Frequencies

GnomAD3 genomes
AF:
0.773
AC:
117540
AN:
151994
Hom.:
45922
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.859
Gnomad AMI
AF:
0.731
Gnomad AMR
AF:
0.812
Gnomad ASJ
AF:
0.758
Gnomad EAS
AF:
0.864
Gnomad SAS
AF:
0.872
Gnomad FIN
AF:
0.734
Gnomad MID
AF:
0.682
Gnomad NFE
AF:
0.706
Gnomad OTH
AF:
0.764
GnomAD2 exomes
AF:
0.775
AC:
194311
AN:
250840
AF XY:
0.773
show subpopulations
Gnomad AFR exome
AF:
0.868
Gnomad AMR exome
AF:
0.873
Gnomad ASJ exome
AF:
0.765
Gnomad EAS exome
AF:
0.854
Gnomad FIN exome
AF:
0.745
Gnomad NFE exome
AF:
0.702
Gnomad OTH exome
AF:
0.753
GnomAD4 exome
AF:
0.733
AC:
1069192
AN:
1458986
Hom.:
394636
Cov.:
34
AF XY:
0.736
AC XY:
534390
AN XY:
726006
show subpopulations
African (AFR)
AF:
0.862
AC:
28819
AN:
33424
American (AMR)
AF:
0.866
AC:
38695
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.758
AC:
19795
AN:
26100
East Asian (EAS)
AF:
0.862
AC:
34157
AN:
39638
South Asian (SAS)
AF:
0.858
AC:
74024
AN:
86228
European-Finnish (FIN)
AF:
0.741
AC:
39501
AN:
53294
Middle Eastern (MID)
AF:
0.708
AC:
4076
AN:
5756
European-Non Finnish (NFE)
AF:
0.708
AC:
785068
AN:
1109562
Other (OTH)
AF:
0.747
AC:
45057
AN:
60280
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
13123
26247
39370
52494
65617
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19832
39664
59496
79328
99160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.774
AC:
117660
AN:
152112
Hom.:
45980
Cov.:
32
AF XY:
0.777
AC XY:
57746
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.860
AC:
35684
AN:
41514
American (AMR)
AF:
0.812
AC:
12411
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.758
AC:
2628
AN:
3468
East Asian (EAS)
AF:
0.864
AC:
4469
AN:
5172
South Asian (SAS)
AF:
0.872
AC:
4201
AN:
4820
European-Finnish (FIN)
AF:
0.734
AC:
7763
AN:
10570
Middle Eastern (MID)
AF:
0.682
AC:
199
AN:
292
European-Non Finnish (NFE)
AF:
0.707
AC:
48022
AN:
67970
Other (OTH)
AF:
0.766
AC:
1618
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1350
2701
4051
5402
6752
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
856
1712
2568
3424
4280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.732
Hom.:
174086
Bravo
AF:
0.778
ESP6500AA
AF:
0.858
AC:
3782
ESP6500EA
AF:
0.697
AC:
5990
ExAC
AF:
0.769
AC:
93360
Asia WGS
AF:
0.890
AC:
3092
AN:
3478
EpiCase
AF:
0.705
EpiControl
AF:
0.709

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Jun 24, 2013
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 22, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dilated cardiomyopathy 1JJ Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
16
DANN
Benign
0.19
DEOGEN2
Benign
0.0051
T;T;T;T
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.40
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.019
T;.;.;T
MetaRNN
Benign
9.8e-7
T;T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
3.5
PrimateAI
Benign
0.27
T
PROVEAN
Benign
1.4
N;N;N;N
REVEL
Benign
0.22
Sift
Benign
1.0
T;T;T;T
Sift4G
Benign
0.53
T;T;T;T
Vest4
0.039
MPC
0.12
ClinPred
0.0088
T
GERP RS
5.9
gMVP
0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2032567; hg19: chr6-112457390; COSMIC: COSV57893884; API